The role of Work Package 5 aims to generate genetically modified (GM)
A. gambiae lines that are immune (refractory) to
P. falciparum infections. It will exploit available knowledge on mosquito immunity genes and macromolecular protease inhibitors.
The team leader for Work Package 5 is Dr Gareth Lycett.